DanCann Pharma towards commercialisation with rights issue
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Nyhet från partner

DanCann Pharma towards commercialisation with rights issue

DanCann Pharma towards commercialisation with rights issue

For DanCann, the aim is clear – to give patients who lack treatment options a better life through medical cannabis and cannabinoids.

After building a solid portfolio of products, the next step for the Danish pharma company is commercialisation. In order to take this step, the company is now conducting a rights issue that, if.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln hos Biostock

Nyhetsbrev